0 results available. Select is focused ,type to refine list, press Down to open the menu,
Exelixis, Inc., an oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States. The company offers CABOMETYX tab...
The following section summarizes insights on Exelixis Inc's Capital Expenditures Margin:
We've identified the following companies as similar to Exelixis Inc because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.
To view the full list of supported financial metrics please see Complete Metrics Listing.
Metrics similar to Capital Expenditures Margin in the efficiency category include:
Capital expenditures expressed as percent of revenue.
The capital expenditures margin measures a company’s capital expenditures as a percentage of the revenue. The formula to calculate capital expenditures margin and an example calculation for Exelixis’s trailing twelve months is outlined below:
Capital Expenditures Margin = Capital Expenditures / Total Revenue
1.3% = 28.435 M / 2.169 B
The tables below summarizes Exelixis’s performance over the last five years:
| Fiscal Year | Capital Expenditures | Revenue | Margin |
|---|---|---|---|
| 2020-12-31 | 30.345 M | 987.5 M | 3.1% |
| 2021-12-31 | 54.225 M | 1.435 B | 3.8% |
| 2022-12-31 | 27.706 M | 1.611 B | 1.7% |
| 2023-12-31 | 40.469 M | 1.83 B | 2.2% |
| 2024-12-31 | 28.435 M | 2.169 B | 1.3% |
The tables below summarizes Exelixis’s performance over the last four quarters:
| Quarter Ending | Capital Expenditures | Revenue | Margin |
|---|---|---|---|
| 2024-03-31 | 9.691 M | 425.2 M | 2.3% |
| 2024-06-30 | 6.57 M | 637.2 M | 1.0% |
| 2024-09-30 | 8.197 M | 539.5 M | 1.5% |
| 2024-12-31 | 3.977 M | 566.8 M | 0.7% |
You can read more about Capital Expenditures here.
The chart above depicts the distribution of capital expenditures margin for companies operating in the Healthcare sector in the Developed economic region. Over 1,970 companies were considered in this analysis, and 1,919 had meaningful values. The average capital expenditures margin of companies in the sector is 7.6% with a standard deviation of 24.0%.
Exelixis Inc's Capital Expenditures Margin of 1.3% ranks in the 48.8% percentile for the sector. The following table provides additional summary stats:
| Economic Risk Region | Developed |
| Total Constituents | 1,979 |
| Included Constituents | 1,919 |
| Min | 0.0% |
| Max | 244.5% |
| Median | 1.4% |
| Mean | 7.6% |
| Standard Deviation | 24.0% |
You can find companies with similar capital expenditures margin using this stock screener.